JCI rebounded at closing bell
22 Oct 2024 17:20
At the closing of afternoon session on Indonesia Stock Exchange (IDX) today (22/10), Jakarta Stock Price Composite Index arrived at 7,789.07, climbing from 7,764.73 seen in the morning.
First half down, PEHA booked loss
05 Sep 2024 11:55
The performance of PT Phapros Tbk (PEHA) slowed down in the first half (H1) of 2024 compared to the same period in 2023.
Investing 1.12 billion shares, Denaya Cakra becomes a new investor in Bukaka Teknik Utama (BUKK)
02 Jan 2024 15:04
On Thursday, December 21, PT Bukaka Teknik Utama Tbk (BUKK), which specialises in manufacturing and providing specific equipment in the construction sector, welcomed PT Denaya Cakra Cipta as a new investor.
Brand-name drugs sales rose 14.9%, Phapros’s profit still declined
27 Jul 2023 15:58
Although its profit went down by almost 30% in the first half of 2023, PT Phapros Tbk (PEHA) managed to record an increase in brand-name drugs sales.
PEHA to raise its dividend, reaching IDR 11.23 billion this year
12 Jun 2023 11:58
PT Phapros Tbk (PEHA) arranges the dividend distribution of IDR 11.23 billion from its net profit in 2022.
Q1 2023 performance slows down, PEHA to give out dividend
08 Jun 2023 17:33
PT Phapros Tbk (PEHA), a pharmaceutical product manufacturer, readies dividend of IDR 11.2 billion that will be taken out of its net profit in 2022.
Phapros prepares ethical drug to become growth pillar for 2023
02 May 2023 18:03
PT Phapros Tbk (PEHA) posted growth in sales of ethical drugs, namely branded prescription drugs, up to 8.9% year-on-year (yoy) at the end of the first quarter of 2023
PEHA net profit soars 143%, supported by aggressive market penetration
30 Mar 2023 13:12
PT Phapros Tbk (PEHA) has posted a net profit of IDR 27.4 billion in the 2022 financial year, growing 143% year-on-year (yoy) or from the previous year which reached IDR 11.3 billion.
Preparing new product launch, Phapros eyes double-digit growth in 2023
12 Jan 2023 15:19
PT Phapros Tbk (PEHA), a pharmaceutical company under PT Kimia Farma Tbk (KAEF), seeks double-digit growth in 2023 through the launch of new products.
